+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Neurovascular Catheters Market by Product Type, Material, Coating Type, Application, End User, Distribution Channel - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337485
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Neurovascular Catheters Market is projected to reach USD 5.97 Billion in 2026. It is expected to continue growing at a CAGR of 12.64%, reaching USD 12.45 Billion by 2032.

Neurovascular catheters are essential devices for ischemic stroke thrombectomy, aneurysm coiling, flow-diversion support, aspiration, vascular access, and diagnostic cerebral angiography. Demand is anchored in verified disease burden: the World Health Organization identifies stroke as a leading global cause of death and disability, while the U.S. Centers for Disease Control and Prevention reports more than 795,000 strokes annually in the United States, with ischemic strokes representing about 87% of cases.

Market momentum is tied to faster stroke recognition, expansion of comprehensive stroke centers, and evidence-based endovascular care. Product differentiation increasingly centers on trackability, torque response, lumen size, aspiration efficiency, distal access stability, radiopacity, kink resistance, and compatibility with stent retrievers, embolic coils, balloons, guidewires, and adjunctive neurovascular devices.

Transformative Shifts in the Neurovascular Catheter Landscape

The neurovascular catheter landscape is shifting from procedure-enabling devices to integrated tools within time-critical stroke systems. AHA/ASA guidelines support mechanical thrombectomy for selected large vessel occlusion patients up to 24 hours from last known well when advanced imaging criteria are met, expanding the treatment pathway beyond early-window intervention.

Hospitals are prioritizing catheter platforms that shorten device exchanges, improve distal navigation, maintain stable support in tortuous anatomy, and support radial as well as femoral access. At the same time, EU MDR scrutiny, FDA quality expectations, and hospital value analysis committees are raising the bar for clinical evidence, post-market surveillance, biocompatibility documentation, human factors, and supply resilience.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is having a cumulative impact across the neurovascular catheter value chain by improving patient identification, procedural planning, and operational throughput. FDA-cleared AI triage tools for CT and CTA support rapid detection and notification of suspected large vessel occlusion, helping stroke teams reduce door-to-notification and door-to-puncture delays where workflow integration is effective.

AI is also influencing R&D through computational modeling, image-based anatomy mapping, virtual simulation, manufacturing quality analytics, and predictive maintenance of production systems. While catheter navigation remains physician-controlled, AI-enabled imaging, workflow orchestration, case prioritization, and predictive inventory planning are strengthening adoption of advanced neurovascular access, aspiration, and microcatheter systems.

Key Regional Insights

Asia-Pacific carries a substantial stroke burden because of population scale, aging, hypertension prevalence, diabetes, smoking exposure in several countries, and uneven access to advanced stroke centers. Japan, South Korea, Australia, and major Chinese cities show strong adoption of endovascular therapy supported by tertiary hospitals, specialist training, and advanced imaging availability, while India and ASEAN markets are expanding through public and private hospital investment, stroke awareness programs, and gradual development of neurointerventional capacity.

North America remains evidence-driven, supported by FDA-cleared technologies, established reimbursement pathways, clinical guideline adherence, and dense comprehensive stroke center networks in metropolitan areas. Europe benefits from established neurointerventional expertise, national stroke strategies, and cross-border clinical research activity, but faces EU MDR transition costs and documentation intensity that can affect product availability and adoption timing. Latin America, led by Brazil and Mexico, is expanding from a smaller base as urban hospitals add thrombectomy capabilities, although affordability, uneven reimbursement, and specialist concentration remain key barriers. The Middle East, particularly GCC states, is investing in specialist hospitals, advanced imaging, and medical tourism-linked tertiary care, while Africa remains constrained by limited CT/CTA availability, trained neurointerventional specialists, referral infrastructure, and catheter affordability, creating demand for training, access partnerships, and durable supply models.

Key Group Insights

ASEAN demand is shaped by a large stroke burden, rapid urbanization, rising noncommunicable disease prevalence, and variable stroke infrastructure across member countries, creating opportunities for training-linked device adoption and referral-network development. The GCC is accelerating uptake through premium hospital investment, centralized procurement, stroke service modernization, and government-led healthcare transformation programs. The European Union combines high clinical sophistication with stricter MDR compliance requirements, favoring neurovascular catheter portfolios supported by robust technical files, post-market clinical follow-up, and real-world performance evidence.

BRICS markets represent high-volume clinical need, especially in China, India, and Brazil, but require localization, pricing discipline, physician education, and regulatory navigation aligned with domestic device policies. G7 countries lead in clinical trials, reimbursement maturity, quality-system enforcement, and early adoption of advanced catheter technologies, including large-bore aspiration systems, distal access catheters, and next-generation microcatheters. NATO markets add emphasis on supply security, domestic or allied manufacturing capacity, cyber-resilient hospital infrastructure, and continuity of critical medical device access during geopolitical or logistics disruptions.

Key Country Insights

The United States leads in neurovascular catheter adoption due to stroke center density, FDA-cleared innovation, mature thrombectomy workflows, and strong integration of emergency medical services with comprehensive stroke centers. Canada emphasizes evidence-based access across provincial systems, with adoption influenced by regional referral pathways and specialist availability, while Mexico and Brazil are expanding specialized neurointerventional capacity, especially in major urban hospitals where imaging, intensive care, and trained operators are concentrated.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from mature stroke networks, national or regional thrombectomy pathways, and established neurointerventional training, although procurement rules, hospital budget pressure, and MDR compliance affect adoption timing. Russia maintains demand in large tertiary centers with neurovascular expertise, but access outside major cities remains less uniform. In Asia-Pacific, China and India offer scale driven by high stroke burden and expanding tertiary care, Japan and South Korea emphasize high-precision neurointervention, advanced imaging, and physician specialization, and Australia supports guideline-based stroke care through advanced metropolitan networks, telestroke coordination, and regional retrieval systems.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence generation that links catheter performance to procedural efficiency, first-pass effect, reperfusion success, complication reduction, reduced device exchanges, and total episode-of-care value. Clinical education should focus on device selection, distal access strategy, aspiration technique, radial versus femoral access considerations, imaging interpretation, and complication management across both high-volume and emerging stroke centers.

Commercial teams should pair premium innovation with tiered portfolios for cost-sensitive markets while maintaining consistent quality, traceability, and regulatory documentation. Manufacturers should strengthen dual sourcing, regulatory readiness, AI-enabled quality systems, sterile packaging validation, and physician feedback loops. Partnerships with imaging AI developers, stroke networks, emergency care programs, and training societies can improve adoption while supporting measurable improvements in time-to-treatment and procedural consistency.

Research Methodology

This executive summary is based on secondary research from verified public and institutional sources, including WHO and CDC stroke data, AHA/ASA clinical guidelines, FDA device databases, EU MDR regulatory guidance, peer-reviewed neurointerventional literature, hospital stroke center standards, clinical trial publications, and public health agency resources.

The methodology triangulates disease burden, guideline eligibility, regulatory trends, hospital purchasing behavior, neurointerventional workflow requirements, and technology adoption indicators. Insights were validated through cross-source comparison and excluded unsupported market-size, market-share, and forecast claims, ensuring that conclusions remain data-backed, clinically grounded, and relevant for neurovascular catheter market analysis.

Conclusion

The neurovascular catheters market is advancing as stroke systems expand, thrombectomy eligibility becomes more operationalized, and hospitals demand devices that improve speed, distal access, aspiration performance, and procedural confidence. Verified epidemiology and clinical guidelines support sustained clinical need for aspiration catheters, microcatheters, guide catheters, balloon guide catheters, and distal access systems.

Future competitiveness will depend on clinical evidence, regulatory execution, AI-enabled workflow integration, operator training, and the ability to serve both advanced and resource-constrained markets. Organizations that combine innovation with affordability, supply resilience, quality assurance, and measurable clinical support are best positioned for durable growth in neurovascular intervention.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Neurovascular Catheters Market, by Product Type
7.1. Microcatheters
7.2. Balloon Catheters
7.3. Access Catheters
7.4. Embolization Catheters
8. Neurovascular Catheters Market, by Material
8.1. Polyether Block Amide
8.2. Polyethylene
8.3. Polyurethane
8.4. Fluorinated Ethylene Propylene
8.5. Nylon
9. Neurovascular Catheters Market, by Coating Type
9.1. Coated Catheters
9.1.1. Hydrophilic Coating
9.1.2. Hydrophobic Coating
9.2. Uncoated Catheters
10. Neurovascular Catheters Market, by Application
10.1. Brain Aneurysm
10.1.1. Saccular Aneurysm
10.1.2. Fusiform Aneurysm
10.2. Ischemic Stroke
10.2.1. Embolic Stroke
10.2.2. Thrombotic Stroke
10.3. Arteriovenous Malformations
10.4. Dural Arteriovenous Fistulas
10.5. Intracranial Atherosclerosis
11. Neurovascular Catheters Market, by End User
11.1. Ambulatory Surgery Centers
11.2. Hospitals
11.2.1. Public Hospitals
11.2.2. Private Hospitals
11.3. Specialty Clinics
11.4. Diagnostic Imaging Centers
11.5. Research Institutes
12. Neurovascular Catheters Market, by Distribution Channel
12.1. Online
12.2. Offline
13. Asia-Pacific Neurovascular Catheters Market
14. North America Neurovascular Catheters Market
15. Latin America Neurovascular Catheters Market
16. Europe Neurovascular Catheters Market
17. Middle East Neurovascular Catheters Market
18. Africa Neurovascular Catheters Market
19. ASEAN Neurovascular Catheters Market
20. GCC Neurovascular Catheters Market
21. European Union Neurovascular Catheters Market
22. BRICS Neurovascular Catheters Market
23. G7 Neurovascular Catheters Market
24. NATO Neurovascular Catheters Market
25. United States Neurovascular Catheters Market
26. Canada Neurovascular Catheters Market
27. Mexico Neurovascular Catheters Market
28. Brazil Neurovascular Catheters Market
29. United Kingdom Neurovascular Catheters Market
30. Germany Neurovascular Catheters Market
31. France Neurovascular Catheters Market
32. Russia Neurovascular Catheters Market
33. Italy Neurovascular Catheters Market
34. Spain Neurovascular Catheters Market
35. China Neurovascular Catheters Market
36. India Neurovascular Catheters Market
37. Japan Neurovascular Catheters Market
38. Australia Neurovascular Catheters Market
39. South Korea Neurovascular Catheters Market
40. Competitive Landscape
40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025
41. Company Profiles
41.1. Abbott Laboratories
41.2. Acandis GmbH
41.3. Asahi Intecc Co., Ltd.
41.4. B. Braun Melsungen AG
41.5. Becton, Dickinson and Company
41.6. Boston Scientific Corporation
41.7. Cook Medical LLC
41.8. ICU Medical, Inc.
41.9. Imperative Care Inc.
41.10. Inari Medical, Inc.
41.11. Integer Holdings Corporation
41.12. Integra LifeSciences Holdings Corporation
41.13. Johnson & Johnson Services, Inc.
41.14. Medtronic plc
41.15. Merit Medical Systems, Inc.
41.16. MicroPort Scientific Corporation
41.17. Penumbra, Inc.
41.18. Phenox GmbH
41.19. Rapid Medical Ltd.
41.20. Stryker Corporation
41.21. Teleflex Incorporated
41.22. Terumo Corporation
41.23. Zeus Industrial Products, Inc.
List of Figures
FIGURE 1. GLOBAL NEUROVASCULAR CATHETERS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL NEUROVASCULAR CATHETERS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL NEUROVASCULAR CATHETERS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL NEUROVASCULAR CATHETERS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL NEUROVASCULAR CATHETERS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL NEUROVASCULAR CATHETERS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 23. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 25. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. INDIA NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. JAPAN NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. AUSTRALIA NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SOUTH KOREA NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL NEUROVASCULAR CATHETERS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL NEUROVASCULAR CATHETERS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL NEUROVASCULAR CATHETERS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL MICROCATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MICROCATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MICROCATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BALLOON CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BALLOON CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BALLOON CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ACCESS CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ACCESS CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ACCESS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL EMBOLIZATION CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL EMBOLIZATION CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL EMBOLIZATION CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL POLYETHER BLOCK AMIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL POLYETHER BLOCK AMIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL POLYETHER BLOCK AMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL POLYETHYLENE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL POLYETHYLENE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL POLYETHYLENE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL POLYURETHANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL POLYURETHANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL FLUORINATED ETHYLENE PROPYLENE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL FLUORINATED ETHYLENE PROPYLENE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL FLUORINATED ETHYLENE PROPYLENE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NYLON MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL NYLON MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL NYLON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL COATED CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL COATED CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL COATED CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL HYDROPHILIC COATING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL HYDROPHILIC COATING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL HYDROPHILIC COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HYDROPHOBIC COATING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HYDROPHOBIC COATING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HYDROPHOBIC COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL UNCOATED CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL UNCOATED CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL UNCOATED CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BRAIN ANEURYSM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BRAIN ANEURYSM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BRAIN ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL SACCULAR ANEURYSM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL SACCULAR ANEURYSM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL SACCULAR ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL FUSIFORM ANEURYSM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL FUSIFORM ANEURYSM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL FUSIFORM ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL EMBOLIC STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL EMBOLIC STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL EMBOLIC STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL THROMBOTIC STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL THROMBOTIC STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL THROMBOTIC STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ARTERIOVENOUS MALFORMATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ARTERIOVENOUS MALFORMATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ARTERIOVENOUS MALFORMATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DURAL ARTERIOVENOUS FISTULAS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DURAL ARTERIOVENOUS FISTULAS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DURAL ARTERIOVENOUS FISTULAS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL INTRACRANIAL ATHEROSCLEROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL INTRACRANIAL ATHEROSCLEROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL INTRACRANIAL ATHEROSCLEROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 142. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 143. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 144. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 145. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 147. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 148. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 150. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 162. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 165. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 166. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 167. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 169. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 170. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 172. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 175. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 176. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 177. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 178. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 180. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 181. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 183. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 184. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 185. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 186. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 187. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 188. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 189. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 190. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 191. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 192. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 194. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 206. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 207. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 208. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 209. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 210. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 211. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 212. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 213. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 214. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 216. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 217. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 218. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 219. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 220. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 221. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 222. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 223. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 224. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 225. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 227. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 228. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 229. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 230. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 231. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 232. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 233. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 235. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 236. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 238. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 245. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 246. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 247. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 249. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 250. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 251. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 252. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 253. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 254. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 255. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 256. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 257. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 258. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 259. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 260. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 261. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 262. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 263. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 264. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 265. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 266. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 267. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 268. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 269. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 270. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 271. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 272. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 273. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 274. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 275. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 276. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 277. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 278. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 279. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 280. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 281. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 282. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 283. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 284. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 285. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 286. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 287. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 288. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 289. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 290. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 291. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 292. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 293. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 294. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 295. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 296. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 297. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 298. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 299. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 300. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 301. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 302. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 303. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 304. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 305. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 306. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 307. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 308. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 309. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 310. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 311. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 312. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 313. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 314. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 315. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 316. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 317. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 318. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 319. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 320. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 321. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 322. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 323. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 324. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 325. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 326. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 327. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 328. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 329. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 330. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 331. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 332. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 333. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 334. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 335. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 336. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 337. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 338. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 339. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 340. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 341. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 342. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY COATED CATHETERS, 2018-2032 (USD MILLION)
TABLE 343. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 344. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, 2018-2032 (USD MILLION)
TABLE 345. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
TABLE 346. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 347. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 348. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 349. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 350. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 351. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 352. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TA

Companies Mentioned

The companies featured in this Neurovascular Catheters market report include:
  • Abbott Laboratories
  • Acandis GmbH
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cook Medical LLC
  • ICU Medical, Inc.
  • Imperative Care Inc.
  • Inari Medical, Inc.
  • Integer Holdings Corporation
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Phenox GmbH
  • Rapid Medical Ltd.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Zeus Industrial Products, Inc.

Table Information